Hamilton Health Sciences, Henderson Campus
Hamilton, Ontario, L8V 1C3, Canada
NCT Number: NCT01111032
During this study the investigators will compare the use of two treadmill tests in people diagnosed with cancer. The STEEP treadmill protocol is often used to evaluate the endurance of people diagnosed with cancer, however, since it is based on step increases in speed or ramp, it may not related to normal function. The new test, which is based on the body response to increased activity has not been used with people with cancer but may provide a better approximation of endurance demands during daily function. Our question is whether the new treadmill test can be used to evaluate aerobic function with people with cancer better than the STEEP treadmill test.
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Hamilton, Ontario, L8V 1C3, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 hour
Treadmill test for endurance. Lasts approx 15 min with 45 min recovery
Hamilton Health Sciences Corporation
Other
Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05364372
Behavior, Cancer
Tucson, Arizona, United States
View Trial DetailsNCT07643389
Behavior, Cancer
Calgary, Alberta, Canada
View Trial DetailsNCT06184256
Behavior, Body Weight
Aurora, Colorado, United States
View Trial DetailsNCT01432067
Behavior, Cancer
Bordeaux, France
View Trial Details